Veroscience Drug Patent Portfolio
Veroscience owns 1 orange book drug protected by 22 US patents Given below is the list of Veroscience's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10688094 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US11000522 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US11666567 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US8431155 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US8613947 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US9192576 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US9522117 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US9700555 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US9993474 | Bromocriptine formulations | 30 Apr, 2032 | Active |
US10688155 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders | 07 Jun, 2030 | Active |
US8877708 | Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders | 07 Jun, 2030 | Active |
US9352025 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders | 07 Jun, 2030 | Active |
US9895422 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders | 07 Jun, 2030 | Active |
US7888310 | Methods of identifying responders to dopamine agonist therapy | 25 Jul, 2023 | Expired |
US8137992 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof | 25 Jul, 2023 | Expired |
US8137993 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof | 25 Jul, 2023 | Expired |
US8137994 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof | 25 Jul, 2023 | Expired |
US5716957 | Method for modifying and resetting the bloodstream prolactin levels of a human subject | 10 Feb, 2015 | Expired |
US5679685 | Accelerated release composition containing bromocriptine | 21 Oct, 2014 | Expired |
US5468755 | Therapeutic process for the treatment of the pathologies of Type II diabetes | 21 Nov, 2012 | Expired |
US5756513 | Therapeutic process for the treatment of the pathologies of type II diabetes | 21 Nov, 2012 | Expired |
US5866584 | Therapeutic process for the treatment of the pathologies of type II diabetes | 21 Nov, 2012 | Expired |
Latest Legal Activities on Veroscience's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Veroscience.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 4th Year, Large Entity | 26 Dec, 2023 | US10688094 |
Payment of Maintenance Fee, 4th Year, Large Entity | 26 Dec, 2023 | US10688155 |
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2023 | US8137993 |
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2023 | US8137992 |
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2023 | US8137994 |
Payment of Maintenance Fee, 8th Year, Large Entity | 24 May, 2023 | US9192576 |
Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2022 | US7888310 |
11.5 yr surcharge- late pmt w/in 6 mo, Large Entity | 10 Oct, 2022 | US7888310 |
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US7888310 |
7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 13 May, 2022 | US8877708 |
Payment of Maintenance Fee, 8th Year, Large Entity | 13 May, 2022 | US8877708 |
Payment of Maintenance Fee, 4th Year, Large Entity | 13 Dec, 2021 | US9993474 |
Payment of Maintenance Fee, 4th Year, Large Entity | 20 Aug, 2021 | US9895422 |
Payment of Maintenance Fee, 8th Year, Large Entity | 24 Jun, 2021 | US8613947 |
Post Issue Communication - Certificate of Correction | 16 Jun, 2021 | US11000522 |
Veroscience's Family Patents
Veroscience Drug List
Given below is the complete list of Veroscience's drugs and the patents protecting them.
1. Cycloset
Cycloset is protected by 22 patents, out of which 9 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10688094 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US11000522 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US11666567 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US8431155 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US8613947 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US9192576 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US9522117 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US9700555 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US9993474 | Bromocriptine formulations |
30 Apr, 2032
(7 years from now)
| Active |
US10688155 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
07 Jun, 2030
(5 years from now)
| Active |
US8877708 | Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders |
07 Jun, 2030
(5 years from now)
| Active |
US9352025 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
07 Jun, 2030
(5 years from now)
| Active |
US9895422 | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
07 Jun, 2030
(5 years from now)
| Active |
US7888310 | Methods of identifying responders to dopamine agonist therapy |
25 Jul, 2023
(1 year, 5 months ago)
| Expired |
US8137992 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
25 Jul, 2023
(1 year, 5 months ago)
| Expired |
US8137993 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
25 Jul, 2023
(1 year, 5 months ago)
| Expired |
US8137994 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
25 Jul, 2023
(1 year, 5 months ago)
| Expired |
US5716957 | Method for modifying and resetting the bloodstream prolactin levels of a human subject |
10 Feb, 2015
(9 years ago)
| Expired |
US5679685 | Accelerated release composition containing bromocriptine |
21 Oct, 2014
(10 years ago)
| Expired |
US5468755 | Therapeutic process for the treatment of the pathologies of Type II diabetes |
21 Nov, 2012
(12 years ago)
| Expired |
US5756513 | Therapeutic process for the treatment of the pathologies of type II diabetes |
21 Nov, 2012
(12 years ago)
| Expired |
US5866584 | Therapeutic process for the treatment of the pathologies of type II diabetes |
21 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cycloset's drug page